Skip to main content
An experienced doctor performs a procedure at Brij Medical Centre in Kavi Nagar.
Dr. Anish Aggarwal

Biography

Dr. Anish Aggarwal

Biography:

  • He is an alumnus of AFMC, Pune, and KMC, Manipal.
  • He did his Rheumatology training at the University of Bath, England.

Position:

  • Director, Institute of Rheumatology and Pain, Brij Medical Centre, Ghaziabad.
  • Senior Consultant Rheumatologist: NMH - Mohan Nagar, NCR, and CHC - Dehradun.

Skills: 

  • Uniquely positioned as a dual specialist in Rheumatology and Pain Management, he brings over three decades of clinical and research expertise to provide comprehensive management of musculoskeletal diseases.

Activities: 

  • A pioneer in digital health, he established one of the region's earliest dedicated web consultation portals, www.arthritiscare.co.in, in 2002. 
  • Backed by a meticulous quarter-century repository of patient data, he regularly presents real-world evidence globally. 
  • His landmark 15-year cohort study on high-molecular-weight Visco-supplementation in knee osteoarthritis was recently published in the peer-reviewed Journal of Cartilage & Joint Preservation. 
  • His extensive publications span Bone Mineral Density (BMD) analysis, osteoporosis, joint preservation, and multimodal analgesia. 
  • He has presented many papers and lectures throughout India and abroad. He regularly speaks at CME programs. 
  • His work as an author, researcher, and contributor in academic and scientific publishing can be viewed under his Open Researcher and Contributor ID (ORCID ID): 0009-0001-9867-5991

Qualification, Designations & Posts Held

Qualification

  • Primary Education: The Doon School, Dehradun
  • Graduation: M.B.B.S. – AFMC, Pune University (1984–1989)
  • Post Graduation: M.D. – KMC, Mangalore (1991–1993)
  • Rheumatology training: PGD-PCR – University of Bath, England

Present Positions

  • Director – Institute of Rheumatology and Pain, Brij Medical Centre, KK-54, Kavi Nagar, Ghaziabad (U.P.)
  • Senior Consultant Rheumatologist - Narinder Mohan Hospital (NMH), Mohan Nagar, and CHC, Dehradun

Affiliations

  • Life Member – IRA, ISBMR, ISA, IMA, IASSP, SOAR, IOF.

Positions Held in the Past

Senior Consultant Rheumatologist / Director

  • Pushpanjali Crosslay Hospital, NCR
  • Fortis Hospital, Noida
  • Kailash Hospital, Noida
  • Prakash Hospital, Noida

Specialist

  • Ministry of Health, King Fahad Hospital, Kingdom of Saudi Arabia

Academic Position

  • Assistant Professor – Santosh World Medical Academy, Ghaziabad

Professional Leadership Roles

  • Founder Honorary Secretary – ISA, Ghaziabad
  • Vice President – ISA, Uttar Pradesh State
  • Organising Secretary – UPANCON 1999, ISA U.P. State
  • Treasurer – Ghaziabad Nursing Homes Association
  • Organising Treasurer – UPNCON 2004, UPNHA U.P. State

Papers Presented & Publications

Book Chapters:

International Journal publication:

  • Anish Kumar Aggarwal, Nakul Aggarwal, Jane Fitzpatrick, Very-high-molecular-weight vs High-molecular-weight hyaluronic acid injections show long-term sustained benefits in the treatment of osteoarthritis of the knee: a 15-year Indian cohort study. Journal of Cartilage & Joint Preservation, Volume 4, Issue 4, 2024, 00213, ISSN 2667-254. https://doi.org/10.1016/j.jcjp.2024.100213. 

Papers Published:

  • Real-Time Outcome of Very High Molecular Weight Iaha After Intra-Articular Glucocorticoids on the Progression of Joint Space Narrowing in KOA. - Aplar-25 I Fukuoka I Japan 
  • Long-Term Sustained Benefits of Viscosupplementation with Different Molecular Weight Intra-Articular Hyaluronic Acids in the Treatment of Osteoarthritis of the Knee. Hav-Oak. A Retrospective Indian Cohort Study of More Than 15 Years - COA Annual Conference 24 | Halifax, Nova Scotia, Canada, CASEM Annual Symposium 24 | Niagara Falls, Canada, WCO-IOF-ESCEO 24 | London, UK
  • AB1192 - Response to Viscosupplementation with Different Types of Intra-Articular Hyaluronic Acids in Osteoarthritis of the Knee - A Retrograde Indian Cohort Study of More Than 15 Years of Longitudinal Data. - EULAR-23 | Milan, Italy  
  • AB1028 - Regressive Bone Mineral Density Trends Seen with Delay in Follow-Up of Denosumab Treatment Due to the Pandemic-Induced Lockdown - A Single-Centre Indian Experience. - EULAR-22 | Copenhagen, Denmark 
  • AB1015 - Sustained Synergistic Effect on Bone Mineral Density Trend with Short-Term Combination of Teriparatide and Denosumab Followed by Denosumab Alone in Postmenopausal Women - A Single Indian Centre Experience.- EULAR-22 | Copenhagen, Denmark  
  • AB0852 - Long-Term Follow-Up of Viscosupplementation with Different Types of Intra-Articular Hyaluronic Acid in Osteoarthritis of the Knees. - EULAR-20 | Frankfurt, Germany  
  • Treatment Outcome by Measuring the Trend of Bmd Versus Bmc by Dual-Energy X-Ray Absorptiometry (DXA)of the Spine. - IOF-Regional, 7th Asia-Pacific Osteoporosis Conference 2018 I Sydney, Australia
  • Time taken for significant changes in Serial Bone Mineral Density Analysis after treatment with Bisphosphonates and Parathyroid Hormone. - APLAR 2016 - Shanghai, China. & EULAR 2017 I Madrid, Spain
  • Peripheral BMD testing for Osteoporosis screening - A bane that should be banned. - APLAR 2016 I Shanghai, China
  • Data Analysis of Bone Mineral Density changes after one year of Zoledronic acid 5 mg infusion. - IRACON 2013 - Kolkata, India.
  • Data Analysis of Bone Mineral Density changes after one year of Teriparatide 20 ug/day Therapy. - IRACON 2013 - Kolkata, India.
  • Discordance between Diagnosis of Osteoporosis using Spine and Hip Bone Densitometry in Males as compared to Females. - ESCEO13-IOF - Rome, Italy. April 17-20, 2013.
  • Long-term (1yr) efficacy and safety of a single 6 mL injection of Hylan G-F 20 in Indian patients with Symptomatic Knee OA. - EULAR 2012 - Berlin, Germany.
  • Evaluation of the efficacy of Diacerein vs Glucosamine Sulphate in OA of the Knees. - ACR 2008 - San Francisco, USA.
  • Evaluation of the efficacy of IA VES with Hylan GF 20 after joint preparation in OA of the Knees. - EULAR 2007 - Barcelona, Spain. 
  • Evaluation of the efficacy of Diacerein vs Glucosamine Sulphate in OA of the Knees. EULAR 2007. - Barcelona, Spain.
  • Pain in Osteoarthritis of the Knee Evaluation by ‘Pain-detect’. -IRACON 2007 - Khajuraho, India.
  • Pulse therapy for SpA. - IRACON 2007 - Khajuraho, India.
  • Evaluation of the efficacy of intra-articular viscoelastic supplementation with HA after joint preparation in osteoarthritis of the knee. - APLAR 2006 - Kuala Lumpur, Malaysia.
  • Intra-articular viscoelastic supplementation after joint preparation in Osteoarthritis of the Knee. - IRACON 2005 - Hyderabad, India.

Recent International Talks:-

  • 2024 June 13 - The Pursuit of Joint Preservation: Impact of Very High Molecular Weight (> 10 kDa) and Delay Time to TKR. Lunch Symposium – C0A – Halifax, Canada
  • 2024 June 07 - HA In the Treatment of OA. My Experience - German Bioventus Team Education, Webinar, Germany
  • 2024 June 06 - New Insights of HA in Knee OA Management -  Bournemouth Vitality Stadium, Bournemouth, UK
  • 2024 June 05 - New Insights of HA in Knee OA Management - MedEd - Bristol Harbour Hotel, Bristol, UK
  • 2024 June 05 - HA In the Treatment of OA. My Experience -   Internal - UKI Bioventus Team Education - Bath, Somerset, UK
  • 2024 May 29 - The Pursuit of Joint Preservation: Impact of Very High Molecular Weight (> 10 kDa) and Delay Time to TKR. Lunch Symposium – CASEM – Niagara Falls, Canada
  • 2024 Apr 19 - Discussion on IAHA -   Lunch Meeting – Bioventus – London, UK
  • 2023 July 21 - Use of IA-HA in OA: Outcome of Long-term Follow-up & the way forward - International Panel Discussion - Bioventus.

Recent Speaker Programs & CMEs :-

Multiple CME talks on RA, OA, AS, Osteoporosis, Biologics, and pain management across India & international forums.

Conferences and CME

Regular attendee and presenter at national and international Conferences to update himself with the latest and future in his field of practice:

  • ACR - American College Of Rheumatology Conference >10 times Attendee
  • EULAR - Annual European Congress of Rheumatology > 10 times Attendee
  • APLAR - Asia Pacific League against Rheumatism > 10 times Attendee
  • IRACON - Indian Rheumatology Association Conference > 25 times Attendee
  • Regular attendee of Other Conferences Like IOF, Pain International Conferences 

Group therapy and Patient Education

He holds public and patient education programs regularly at his state of the art facility at the Institute of Rheumatology and pain, Brij medical Centre, Ghaziabad.

He runs Group therapy sessions for patients and their relatives and Rheumatology treatment camps also.

Advisory board position

He is and has been on the advisory board of many National and International Companies. He is a regular speaker in CME programs and attends regular CME programs and updates from them. To name a few: Bioventus, Eli Lilly, Pfizer, Novartis, Janssen, Aventis, LG, Dr Reddy's, Zydus, Cadila, Cipla, IPCA, Intas Pharmaceuticals, Torrent, Lupin, Emcure, Alkem Laboratories & RPG.